{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:29:21Z","timestamp":1787671761341,"version":"build-2736575974"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00210-026-05549-6","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T03:37:50Z","timestamp":1780889870000},"page":"18215-18226","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fabrication of vesicle-incorporated etoposide-loaded nanocochleates for improved anticancer efficacy"],"prefix":"10.1007","volume":"399","author":[{"given":"Shivappa N.","family":"Nagoba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay R.","family":"Fugate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Dodiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin S.","family":"Mali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudarshan","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod B.","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"5549_CR1","doi-asserted-by":"crossref","unstructured":"Ahmad Z, Zhang X, Imran M, Zhong H, Andleeb S, Zulekha R, Liu G, Ahmad I, Coulon F (2021) Production, functional stability, and effect of rhamnolipid biosurfactant from Klebsiella sp. on phenanthrene degradation in various medium systems. Ecotoxicol Environ Saf 207:111514, 111514","DOI":"10.1016\/j.ecoenv.2020.111514"},{"key":"5549_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107898","author":"D Alonso-Carrillo","year":"2023","unstructured":"Alonso-Carrillo D, Arias-Betancur A, Carreira-Barral I, Fontova P, Soto-Cerrato V, Garcia-Valverde M, P\u00e9rez-Tom\u00e1s R, Quesada R (2023) Small molecule anion carriers facilitate lactate transport in model liposomes and cells. iScience. https:\/\/doi.org\/10.1016\/j.isci.2023.107898","journal-title":"iScience"},{"key":"5549_CR3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jconrel.2022.08.001","volume":"351","author":"M Ashrafizadeh","year":"2022","unstructured":"Ashrafizadeh M, Delfi M, Zarrabi A, Bigham A, Sharifi E, Rabiee N, Paiva-Santos AC, Kumar AP, Tan SC, Hushmandi K (2022) Stimuli-responsive liposomal nanoformulations in cancer therapy: pre-clinical & clinical approaches. J Control Release 351:50\u201380","journal-title":"J Control Release"},{"key":"5549_CR4","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.fct.2018.11.038","volume":"124","author":"S Ayd\u0131n","year":"2019","unstructured":"Ayd\u0131n S, Bacanl\u0131 M, Anlar HG, \u00c7al T, Ar\u0131 N, Bucurgat \u00dc\u00dc, Ba\u015faran AA, Ba\u015faran N (2019) Preventive role of Pycnogenol\u00ae against the hyperglycemia-induced oxidative stress and DNA damage in diabetic rats. Food Chem Toxicol 124:54\u201363","journal-title":"Food Chem Toxicol"},{"key":"5549_CR5","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S0022-2836(65)80093-6","volume":"13","author":"AD Bangham","year":"1965","unstructured":"Bangham AD, Standish MM, Watkins JC (1965) Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 13:238-IN227","journal-title":"J Mol Biol"},{"key":"5549_CR6","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-024-02988-3","volume":"26","author":"L Bhute","year":"2024","unstructured":"Bhute L, Dighe S, Katari O, Yadav V, Jain S (2024) Bifunctional oxaliplatin (IV) prodrug based pH-sensitive PEGylated liposomes for synergistic anticancer action against triple negative breast cancer. AAPS PharmSciTech 26:2","journal-title":"AAPS PharmSciTech"},{"key":"5549_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125296","volume":"671","author":"S Chandani","year":"2025","unstructured":"Chandani S, Dighe S, Katari O, Yadav V, Jain S (2025) Crosslinked hydroxypropyl-\u03b2-cyclodextrin nanoparticles for improved efficacy of venetoclax against triple negative breast cancer. Int J Pharm 671:125296","journal-title":"Int J Pharm"},{"key":"5549_CR8","volume":"15","author":"\u00d6 \u00c7oban","year":"2018","unstructured":"\u00c7oban \u00d6, De\u011fim Z (2018) Development of nanocochleates containing erlotinib HCl and dexketoprofen trometamol and evaluation of in vitro characteristic properties. Turk J Pharm Sci 15:16","journal-title":"Turk J Pharm Sci"},{"key":"5549_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12247-024-09911-0","volume":"20","author":"D Elkhayat","year":"2025","unstructured":"Elkhayat D, Abdelmalak NS, Amer R, Awad HH (2025) Ezetimibe loaded nanostructured lipid carriers tablets: response surface methodology, in-vitro characterization, and pharmacokinetics study in rats. J Pharm Innov 20:11","journal-title":"J Pharm Innov"},{"key":"5549_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.crphar.2022.100083","volume":"3","author":"MK Gupta","year":"2022","unstructured":"Gupta MK, Sansare V, Shrivastava B, Jadhav S, Gurav P (2022) Fabrication and evaluation of mannose decorated curcumin loaded nanostructured lipid carriers for hepatocyte targeting: In vivo hepatoprotective activity in Wistar rats. Curr Res Pharmacol Drug Discov 3:100083","journal-title":"Curr Res Pharmacol Drug Discov"},{"key":"5549_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2026.102910","volume":"72","author":"O Katari","year":"2026","unstructured":"Katari O, Yadav V, R R, Garg P, Jain S (2026) Cisplatin(IV)-fatty acid prodrug-bound albumin nanoparticles: in vitro, in silico, and in vivo evaluation in breast cancer therapy. Nanomedicine 72:102910","journal-title":"Nanomedicine"},{"key":"5549_CR12","doi-asserted-by":"publisher","unstructured":"Kristensen S, Hassan K, Andersen NS, Steiniger F, Kuntsche J (2023) Feasibility of the preparation of cochleate suspensions from naturally derived phosphatidylserines. Front Med Technol Volume 5:1241368. https:\/\/doi.org\/10.3389\/fmedt.2023.1241368","DOI":"10.3389\/fmedt.2023.1241368"},{"key":"5549_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.inoche.2024.113806","volume":"173","author":"M Maghimaa","year":"2025","unstructured":"Maghimaa M, Sagadevan S, Suryadevara PR, Sudhan HH, Burle GSR, Ruokolainen J, Nelson VK, Kesari KK (2025) Cytotoxicity and targeted drug delivery of green synthesized metallic nanoparticles against oral cancer: a review. Inorg Chem Commun 173:113806","journal-title":"Inorg Chem Commun"},{"key":"5549_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14081601","volume":"14","author":"N Munot","year":"2022","unstructured":"Munot N, Kandekar U, Giram PS, Khot K, Patil A, Cavalu S (2022) A comparative study of quercetin-loaded nanocochleates and liposomes: formulation, characterization, assessment of degradation and in vitro anticancer potential. Pharmaceutics 14:1601","journal-title":"Pharmaceutics"},{"key":"5549_CR15","doi-asserted-by":"crossref","unstructured":"Sui D, Song Y, Deng Y (2025) Combination therapy with lipid prodrug liposomes reshapes disease-associated neutrophils to promote the cancer-immunity cycle. J Nanobiotechnol 23:132, 132","DOI":"10.1186\/s12951-025-03179-3"},{"key":"5549_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2025.106628","volume":"105","author":"K Zoeller","year":"2025","unstructured":"Zoeller K, Lindner S, To D, Postina A, Bernkop-Schnuerch A (2025) Enhanced cytotoxicity of exo-and endogenous compounds by hitchhiking lipid-based nanocarriers. J Drug Deliv Sci Technol 105:106628","journal-title":"J Drug Deliv Sci Technol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05549-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05549-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05549-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:50:17Z","timestamp":1787669417000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05549-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":16,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["5549"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05549-6","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"4 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}]}}